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Recent studies (1-3) have shown that hamsters with primary or transplanted 
adenovirus  12  (Ad.  12)-induced  tumors  develop  an  immunologic  response 
against  a  number of virus-specific antigens.  These include  the  type-specific C 
antigen,  an  unidentified antigen in  standard  viral  harvests,  and  one  or more 
previously unrecognized antigens  ("T" antigens)  found in tumor extracts and 
suspensions  of acutely infected  cells  (4).  Of  these,  only  the  latter  is  directly 
demonstrable in tumors by either complement fixation (CF) or fluorescent anti- 
body (FA)  procedures  (5);  the others  have  as  yet  been  identified  in  tumors 
only indirectly,  by the antibody responses of tumor-bearing animals.  All three 
of these antigens invoke type-specific (or 12-18 subgroup specific) CF antibody 
responses,  although a  more broadly group-reactive antibody has been detected 
by the FA procedures (5). To date, all attempts to demonstrate complete virus 
and the group reactive A  antigen in the tumors have been unsuccessful (3,  6). 
The immunological methods employed to date in the study of these  tumor- 
produced viral antigens, i.e.  CF,  FA, and virus neutralization  tests,  are highly 
specific,  but  are unable  to distinguish  separate  reactions  in a  complex system 
unless  chemically  purified  antigens  are  used.  We  have  therefore  turned  to 
another  tool,  immunodiffusion,  in the hope of more clearly distinguishing  the 
various viral antigens manufactured during the course of adenovirus oncogene- 
sis. 
Materials and Methods 
The micro-Ouchterlony test was that described by Crowle (7). A plexiglas mold containing 
a pattern of wells was inserted  on a thin layer of solidifying agar (1 per cent ionagar with 
1 per cent  Na azide) supported  by a glass slide. After the addition  of serum and antigen in 
0.05 ml volumes, the plates were incubated in a moist chamber 48 to 72 hours at room tem- 
perature.  All sera were tested undiluted and unheated. 
The immunoelectrophoresis technique was Crowle's description of Scheidegger's technique 
(8). All tests were done by electrophoresing the antigen. 100 to 150 v current was run for 40 to 
80 minutes  through  a  field containing sodium barbital-buffered  agar  (1.2 per cent ionagar) 
at pH 7.9. After the serum was added, the plates were incubated in a moist chamber 24 hours 
and  read. 
The microcomplement fixation test was that described by Sever (9). The virus neutraliza- 
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tion tests were performed in Rhesus monkey kidney cultures by previously described tech- 
niques (10, 11). 
Antigens.--The  CF antigen titers and gel reactions of the more routinely employed antigen 
preparations are listed in Table I. 
Crude concentrated  viral antigens were prepared  by inoculating KB  cell monolayers  or 
spinner cultures with high titer (106-107 TCIDs0) Ad.  12. Cells and  medium were harvested 
at complete cytopathic effect, then frozen and thawed several times. These crude lysates were 
concentrated 25- to 100-fold by polyvinyl pyrolidine (PVP) and carbowax dialysis.  One prepa- 
ration used in many of the tests, viral concentrate 3, was homogenized three times with fluoro- 
carbon and concentrated 35-fold  with PVP. 
TABLE I 
Serological Reactivity  of Standard  Antigens used in Gel Diffusion  Tests 
•  .  •  Antigen  content 
CF  tlter  and  gel  reaction  vs.  various  sera  (gel  reaction) 
cent pool  hamster  hamster  rabbit  guinea  ] 
pig)  [ 
Ad.  12  ~ra~-concentrate  ~2  25~ 
3 .....................  5  /+,  /+  <  /->64/+  /+  +  +  ] + 
Ad. 12CantigenC6B.1M..]  <8/--  32/+]  /--]  128/+1  /+1  I  f  [ 
Ad.  12 A antigen C6B.05  [ 
M ....................  J  32/+  <8/  /--i  64/+  /+]  +  ? 
Ad.  12  tumor  extract  J  :  !  ] 
pool6 ................  /--  >128/+  >64/+  /--  /--  + 
Ad. 12ce]lpack12BC3...  >128/+  >512/+]  64/+  /+  /+i  +  +  +  + 
Control KB antigen ......  i  /--  4/--I  <4/--,  /+:ill2/+  I  L 
* "Broad"  serum  reacts  with  viral  and  tumor  antigen  preparations,  while  "narrow" 
serum reacts only with tumor extract. 
:~ CF antigen titer/gel reaction. Blank space indicates not tested. 
Concentrated cellular viral antigens  ("cell-pack antigen preparations")  were prepared  by 
infecting human embryonic kidney cells in monolayers and KB cells in monolayers and spin- 
ners with high titered adenovirus  12. The cells were harvested at earliest cytopathic effects 
(CPE) by scraping with a rubber policeman. The medium was removed by centrifugation and 
the cells were resuspended in small quantities of phosphate-buffered saline (106 to 107 cells/ml). 
Preparations were then frozen and thawed several times before use. 
Partially purified viral antigens were obtained by DEAE cellulose column chromatography 
of crude concentrated  viral preparations.  Stepwise elution was carried  out  with  phosphate 
buffers  of increasing molarity. In agreement with earlier reported findings  (12-16),  on other 
adenovirus  types,  an  A  group-specific  and  a  C  type-specific antigen  were  demonstrated. 
However, there  was no serologic  evidence of a  B  (cell-detaching)  antigen.  As reported  by 
Huebner et al.  (2), the group antigen (A) eluted at 0.01 to 0.05 molarity and the type-specific 
antigen (C) at 0.1 to 0.15 molarity. The A and C antigens used  in the gel diffusion  tests had 
been doubly or triply chromatographed. Complement fixation tests showed significant antigen 
titers with little cross contamination of the specific antigens, although all fractions contained LEONARD  D.  BERMAN  AND  WALLACE P.  ROWE  957 
some host cell protein (Table I). One preparation of C  antigen,  C6B.1M, had  a  >64  titer 
against an anti-C Ad. 12 rabbit serum  t and a  <8 titer against an anti-A Ad. 12 rabbit serum.  1 
Tumor antigen preparations were prepared by making 20 to 33 per cent extracts of viable 
adenovirus 12 tumors with a motor-driven tissue grinder. Both primary and transplant tumors 
were used. The tumors were debrided of necrotic tissue and the viable pieces washed several 
times in  phosphate-buffered saline.  The  tissue suspensions were  then ground  to  fine  con- 
sistency and clarified at 2000 RV~ for 20 minutes. 
TABLE  II 
Serological  Reactivity of Standard Sera Used in Gel Diffusion Tests 
Sera 
Human  Ad.  convalescent 
pool 33917 ............. 
Hamster  6155  (Ad.  12 
tumor). 
Hamster  9205' iAd." "i2 
tumor). 
Hamster pool2B iAd.i2" 
tumor) ...............  .. 
Guinea  pig  7179 (hyper- 
immune Ad. 12) ........ 
Rabbit  3-360  (hyperim- 
mune Ad. 12) .......... 
Anti-KB sera 8135 (guinea 
pig) and 3-307 (rabbit).. 
CF antibody titer and gel reaction vs. various antigens 
Ad. 12  Ad. 12 
virus  cell pack 
80/+:  >16/+ 
8o/+  /+ 
160/+  320/+ 
<10/-  >640/- 
160 + 
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* CF antibody titer/gel reaction. Blank space indicates not tested. 
Sera.--The CF antibody titers and gel reactions of the commonly used sera are listed in 
Table II. 
Hamster sera: Two hamster sera, 6155 and 9205, (both from animals with primary tumors) 
were used in most of the tests described. These had high CF titers (Table II) and virus neu- 
tralization titers of 80 and 40 respectively. Sera from many hamsters with large primary or 
transplanted Ad. 12 tumors were also screened against viral and tumor antigen preparations. 
Some of the sera were selected purely at random, and others were selected for high CF anti- 
body titers. 
Guinea pig hyperimmune serum  (7179):  This serum was prepared by inoculating 1 ml of 
high titered Ad. 12 intranasally, followed by 1.5 ml intraperitoneally 3 weeks later. The animal 
was bled out 1 week after the final inoculation. A control antihost cell serum (8135) was pre- 
pared by giving 2 and 1 ml doses of concentrated KB cell lysate in Freund's adjuvant 10 days 
apart. This guinea pig was bled out 9 days after the final inoculation. 
1 Kindly supplied by Dr. H. G. Pereira. 958  ADENOVIRUS  12  TUMORIGENESIS 
Human  adenovirus  convalescent pool  (33917):  This was a  collection  of pooled  human sera 
from military recruits convalescent from recent adenovirus infection. 
Rabbit hyperimmune serum 3-360:  This was a  standard  typing serum prepared  by hyper- 
immunization with crude Ad. 12 KB tissue culture-grown virus by Microbiological Associates, 
Bethesda. A  control rabbit  antihost cell serum (3-307)  was prepared in the same manner. 
Controls.--Antigens which failed to give any positive gel reactions with tumored hamster 
serum included  KB  control cell-pack  antigen,  polyoma and  SV40  hamster  tumor  extracts, 
and CAM-grown Rous sarcoma. Control sera which did not react to Ad.  12 viral and tumor 
antigens included  Schmidt-Ruppin-Rous-tumor hamster serum, and  Yaba facial tumor mon- 
key serum. Three anti-KB cell sera, two rabbits  (3-307 and L001) and one guinea pig (8135), 
were also prepared. These gave lines with Ad. 12 viral preparations which were identified with 
some of the reactions of the anti-Ad.  12 hyperimmune sera. In this way the actual antiviral 
lines of the hyperimmune sera could  be distinguished. These anti-KB sera gave no reaction 
with Ad.  12 tumor antigen. 
FIG.  1.  Reaction of tumored hamster serum to adenovirus 12 viral and tumor antigens. A 
common reaction  to  two  separate  tumor  extracts  crosses and  is distinct  from  the antiviral 
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RESULTS 
Ninety-eight sera from hamsters carrying Ad. 12-induced tumors were tested 
in gel diffusion against  both standard  concentrated viral and  tumor antigens. 
Of these, thirty-one were found to react positively with tumor antigen only, and 
six were found that  reacted  to both viral  and  tumor antigen.  In all  cases  the 
reaction with  tumor antigens was a  single fairly broad line.  The reaction with 
viral antigen was sometimes encountered as a  double line, neither part of which 
was continuous with the anti-tumor reaction. 
Fro. 2. Reaction of tumored hamster serum to various adenovirus 12 viral and tumor anti- 
gens. There is a common reaction line shared by cell-pack antigen,  crude viral antigen, and 
purified C type-specific antigen.  Another  common reaction  between cell-pack antigen  and 
tumor extracts  is distinct  from the first line. 
Fig.  1 shows the reaction of a high-titered hamster serum (No. 6155) against 
both  viral  and  tumor  antigens.  The  antitumor  reaction  appears  as  a  single 
line  which  is  continuous  for  two  different  preparations.  The  identity  of  this 
antigen  line  has  held  true  for four different  tumor extracts.  The  antiviral  re- 
action in Fig.  1 also appears as a single line, which crosses, and is therefore dis- 
tinct from, the antitumor reaction. 
Fig. 2 shows the same hamster serum tested against additional viral and tu- 
mor antigens.  There is a  positive reaction against purified Ad.  12 type-specific 
(C) antigen which is continuous with the  reactions  against  crude  virus,  an  A 
plus  C  mixture,  and  a  cell-pack preparation.  A  second reaction line,  between 
hamsterserum and tumorextract, is shared by the cell-pack antigen preparation; 
a third line shows a reaction only with the A plus C antigen  fraction.  The puri- 
fied group (A) antigen shows no reaction. 960  ADENOVIRUS 12  TUMORIGENESIS 
The  reactions  shown in  Figs.  1 and  2  confirm the  CF  antibody studies  in 
showing  the  response  to  C  but  not  to  A  antigen,  the  distinctness  of  the  C 
reaction from that with tumor extract, and the presence of an antigen in acutely 
infected cells identical to that in tumor extracts. The third line may represent 
yet another antigen whose concentration in the chromatography fractions may 
have been enough to elicit a positive response with serum 6155.  This is probably 
not the usual non-C antigen in viral harvests, which remains unidentified in this 
system. 
Fig. 3 shows the reaction of hamster serum 9205 and human serum pool 33917 
to crude Ad. 12 and purified C antigen. In contrast to serum 6155,  this hamster 
serum reacted to two antigens in the crude virus preparation, one being the C 
Viral  C6B 
Conc. (~  CAgt'~/ 
Po-oi L-.)  ~  C)  k-  ('~ Human 
....  A~  °1 
/  "~'C6B  "JViral Conc. 
CAg  3 
Center well: Hamster Serum 
Fro,  3.  Reaction of tumored hamster serum 9205  and pooled  human convalescent serum 
33917  to viral antigens.  The hamster serum is reacting to two antigens,  one of which is the 
type-specific C  antigen  (C6B  CAg) and the other reaction, shared by  the  human  pool,  is  to 
a previously undescribed antigen  (D) which is distinct from the classical A  and C  antigens. 
antigen.  Surprisingly,  the antigen present in crude virus and absent in  the  C 
fraction is also reacting with the human serum (line D). A third antigen forming 
a broad arc on the sides of the pattern is the A antigen, probably reacting only 
to the human serum. The presence of this line between the human serum and 
the C antigen may indicate contamination of the C fraction with A antigen, or 
migration of the A antigen in viral concentrate 3 past the C well. 
These patterns  demonstrate a  third  antigen  of adenovirus  12  reactive with 
tumored hamster serum; this antigen is also reactive with the human serum and 
is distinct from the classical A and C antigens. Although we cannot exclude the 
possibility that this antigen corresponds to the B antigen of other adenoviruses 
or the non-C viral antigen demonstrated in CF with tumored hamster sera, our 
present feeling, based primarily on  chromatographic  separation and  stability 
studies,  is that  the new antigen is distinct.  For this reason,  we will refer to it 
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Data in Fig. 4 indicate that the D  antigen is also reactive with hyperimmune 
anti-Ad.  12 sera. In this test, two hamster sera and two hyperimmune Ad.  12 
sera were reacted against a  concentrated virus preparation. All sera except the 
guinea pig (7179)  react against the C antigen, and all sera except one hamster 
(6155)  react  against  the  D  antigen.  Neither  hamster  serum  reacts  with  the 
FIG. 4. Reaction of concentrated crude adenovirus 12 viral antigen to tumored hamster and 
hyperimmune sera. Both hamsters react to the C  antigen, one reacts to the D  antigen, and 
neither  reacts  to  the  A  antigen. 
classical A  antigen.  The  two lines marked H  are  different  separate reactions 
given by the  hyperimmune sera.  One of these has been identified  as antihost 
cell reaction, and the other is thought to be antihost as well.  Some other faint 
lines, (not visible in the photograph) were also present as reactions of the ham- 
ster sera. Whether these represent other antigens, or a  splitting of the lines al- 
ready described, is not clear. 
Immunoelectrophoretic Studies.--Most  of the  reactive combinations of anti- 
gens and antisera discussed above were also tested in immunoelectrophoresis, in 
attempts to further separate components of the antigens. Repeated tests demon- 962  ADENOVIRUS  12  TUMORIGENESIS 
strated  only  one  line  with  hamster  serum  and  concentrated  virus,  while  the 
human convalescent serum pool gave at least three distinct  lines. One  of these 
lines,  which  migrated  toward  the  positive  electrode,  appeared  to  correspond 
with the hamster antiviral line, and hence, probably represented the D  antigen. 
Repeated tests of hamster serum against tumor antigen yielded only two posi- 
tive tests; in each case  there  was a single line showing essentially no migration 
of the antigen at pH 7.9. 
Relation  of Gel Diffusion  Reactivity  to  CF  and  Neutralizing  A ntibody.--The 
serologic  reactions  of the  ninety-eight  Ad.  12-tumored  hamster  sera  tested  in 
gel diffusion are summarized in Tables III and IV. Of the six sera which reacted 
with  viral antigen  in gel diffusion,  all  were  positive against  tumor  antigen  as 
TABLE III 
Virus  Neutralizing  and  CF Reactions  of Ad.  12-Tumored  Hamster  Sera  in  Rdation  to  Gel 
Diffusion  Reactions 
Ouchterlony reaction 
Virus and tumor ...... 







Neutralization  Complement fixation 
Viral antigen  Tumor antigen 
No.  Per cent  pos,* 
6  (100) 
7  (23) 
9  (15) 
t~No~  ~  Per cent 
I  6  (100) 
30  (97) 
128/  (46) 
Average  No.  Per cent  titer§  po~ 
101  (10o) 
94  ~  (10o) 






* Test of undiluted  serum. 
:~ A reaction  of at least 3+ at a 1 to 10 dilution. 
§ Geometric mean. 
well,  and  all were positive for neutralizing  antibody and  CF reaction  to viral 
and  tumor  antigens.  Some  of the  antiviral  gel  diffusion  reactions  were  quite 
faint, and it was not possible to determine if they were  against C or D  antigen; 
the  presence  of neutralizing  antibody  indicates  that  these  sera contained  CF 
antibody to C antigen (2). 
The sera which reacted in gel diffusion only against tumor antigen showed CF 
reactivity  comparable  to  the  virus-reactive  group,  but  differed  markedly  in 
the frequency of neutralizing antibody, and, by inference, C antibody. 
The frequency of gel diffusion  reaction  in relation  to magnitude  of CF and 
neutralizing  antibody titer is shown in Table IV. High titer antiviral  CF anti- 
body was  the  most  consistent  indicator  of antitumor  gel diffusion  reactivity; 
this may be due to the fact that animals developing high antiviral  titers have 
had high antitumor CF antibody for a longer time (1). LEONARD  D.  BERMAN  AND  WALLACE  P.  ROWE 
TABLE IV 







High  >80 
Medium  20-40 
Low  < 10 
High  >80 
Medium  2{)-40 
Low  _< 10 
Ouchterlony totals 
High  >20 
Low  1-10 













Ouchterlony  reaction 
Viral  Tumor 
No, pos.  Per cent 
5  15 
1  4 
0  0 
6  8 
0  0 
0  0 
3  33 
3  23 
0  0 
6  6 
No. pos.  Per cent 
28  82 
8  35 
1  2 
34  47 
3  27 
0  0 
5  56 
8  62 
24  32 
37  38 
DISCUSSION 
The above data indicate that there are at least four distinct antigens associ- 
ated with adenovirus type 12, and at least three of these are manufactured in 
the tumor cells. 
Indirect evidence from this and preceding papers (1, 2), indicates that the A 
group-specific antigen is  not  associated with  the  tumor cells.  However, the 
demonstration of virus-like particles in tumor extracts by electron microscopy 
(17), together with the association of A antigen with capsomere substance in 
other adenovirus types (18), is difficult to reconcile with this finding. 
The best known of the viral antigens definitely associated with the tumors is 
the type-specific C antigen. CF reactions of tumored hamster sera with chro- 
matographically purified viral material have previously demonstrated the asso- 
ciation  of this  antigen  with  the  tumors  (2),  and  the gel diffusion reactions 
confirm this. The association of the antiviral gel reaction and the neutralizing 
antibody response also confirm the findings of Huebner et al.  (2). Recent find- 
ings have shown the C antigen to be a complex structure, possibly a viral sub- 
unit (18,  19). 
As yet, little is known about the previously undescribed D  antigen. Chroma- 
tographic separation of Ad. 12 virus preparations sometimes yields a third peak 
of CF antigen activity (in addition to A  and  C)  with crude antisera  (2,  20, 
21). This material may correspond to the D antigen, as the reaction is obtained 964  ADENOVIRUS  12  TUMORIGENESIS 
with the convalescent human serum pool, which is reactive to the D antigen in 
gel diffusion. The fact that the human serum gives this reaction indicates that 
it is not host cell antigen. The chemical and physical nature, the distribution 
among adenovirus types, and the breadth of reactivity of this antigen have yet 
to be determined. 
The most abundant of the viral antigens associated with the tumor cells is 
the so-called "tumor" or "T" antigen(s).  This antigen was first described in 
the  tumors  (1)  and later during  the  early stages  of the lyric cycle in viral- 
infected cells (4). The identity of the antigen from these two sources has been 
confirmed in gel diffusion. In addition,  these studies  showed the  identity of 
tumor antigen derived from different tumors. The fact that this antigen is the 
only antigen so far to be directly demonstrated in the tumors, and that it is the 
most common by far of the hamster antibody responses, indicates that it is the 
most abundant of all the viral antigens in the tumor. 
There is indirect evidence of another viral antigen in the tumors, namely the 
antigen referred to as the non-C antigen in viral harvests. In view of the low 
degree of reactivity of hamster sera against C and D antigens in gel diffusion, 
it seems unlikely that these two antigens can account for the bulk of the anti- 
viral  CF  response.  Various  antigen  treatments  such  as  dialysis at pH  10.5, 
trypsin, and heat can destroy the reactivity of viral preparations with hamster 
sera with high antiviral and low anti-C titer, but will not affect their activity 
with hamster sera with high viral and high anti-C activity (20). However, the 
above procedures will also inactivate the tumor antigen, and it may be possible 
that this other viral antigen is an altered form of the tumor antigen that can 
not give a precipitin reaction or fix complement with low avidity serum. This 
concept is supported by the fact that we not infrequently observe that the so- 
called "narrow hamster sera" (reacting only with tumor antigen) give partial 
CF reactions with standard viral antigen preparations through high serum di- 
lutions. 
Fig. 4 and the immunoelectrophoresis studies indicate that there may be other 
undescribed adenovirus  12 antigens.  Recent studies with  disc-electrophoresis 
(22) have shown at least nine proteins associated with disrupted adenovirus. It 
is conceivable that most of these could act as antigens. 
Table V  summarizes the presently established adenovirus  12 antigens and 
their sources. It is interesting that hyperimmune sera may demonstrate anti- 
bodies to any of the above antigens with the exception of the tumor antigen. 
With one exception  2 only tumored hamster sera have been found to contain 
the "antitumor" antibody. Limited attempts to hyperimmunize with cell-free 
tumor extracts have been unsuccessful (23). 
One Rhesus monkey inoculated with adenovirus 12  at birth was found to contain CF 
antibody to the adenovirus 12 tumor antigen 2 months later. This animal never developed 
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The results of these studies indicate some of the advantages in the use of 
tumored animal sera in gel diffusion. Most previous attempts (24--30) to utilize 
immunodiffusion techniques in the study of cancer immunology were always 
fraught with difficulty because of the use of hyperimmune sera, which have a 
number of antihost cell reactions which usually have to be absorbed out. Tests 
were frequently based on the appearance or absence of one line in a sea of re- 
action. The use of tumored sera provides a direct, clear-cut, specific tool in the 
detection of specific  tumor antigens. There is no doubt that the CF and FA 
tests are more sensitive than the gel diffusion, as evidenced by the above re- 
sults. Also some antibody molecules may be incapable of giving a  precipitin 
reaction  (31).  However, the gel diffusion is highly specific  and is capable of 
dissecting out complex reactions. Also, gel diffusion may be particularly useful 
with species whose antibodies do not fix complement. 
TABLE  V 
Antigenic Content o/Adenovirus  12 Viral and Tumor Pre 
Type of preparation  A  C  D 
Standard concentrated viral harvests ....  +  +  + 
Cell-pack viral antigens..  +  +  + 
Tumor extracts  ....  (4-)*  (4-)* 
Oara~ions 
Other viral  "Tumor 
antigen  antigen" 
Probable 
Probable  + 
(?)  + 
* Presence of these antigens indicated by antibody response only. 
SUMM~RY 
The use of the agar gel diffusion technique has established the  presence of 
three distinct antigenic reactions in the sera of Ad. 12 tumor-bearing hamsters. 
Only one of these antigens is directly demonstrable in the tumor. This "tumor" 
antigen is also formed during early stages of the infectious cycle in tissue culture 
cells.  Other antigens present in the tumor, but only  demonstrable indirectly 
with the use of antibody-containing serum of tumored hamsters, are the classical 
type-specific C antigen, and a new antigen, termed D. 
Of ninety-eight Ad.  12  tumored hamster sera,  six reacted in gel diffusion 
with virus and tumor preparations, and thirty-one with tumor only. 
Sera which reacted in gel diffusion with viral antigen uniformly had neutraliz- 
ing antibody and high titers of CF antibody against viral and tumor antigens; 
however, many sera with comparable antibody titers did not react with the virus 
in gel diffusion. Sera which reacted in gel diffusion only with tumor antigen also 
had high CF antibody titers,  but there was no correlation with neutralizing 
antibody. 
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